Metaplastic Breast Carcinoma — Clinical Trials

MONDO:00060433 active·1 recruitingLast updated: Mar 20, 2026, 5:47 PM

Trial Landscape

Metaplastic Breast Carcinoma has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment2

Procedure1

Biological Therapy1

By Phase

Phase 2

Sponsor Types

Academic/Other2NIH1

Trial Locations

United States2 trials

Brazil1 trial

Guam1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

3 Trials

Phase 2Recruiting

NCT05660083

Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)

Sponsor:The Methodist Hospital Research Institute

United StatesStarted: Jan 2023Est. completion: Dec 2028Updated: Feb 2026

Phase 2Active, Not Recruiting

NCT02834013

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Sponsor:National Cancer Institute (NCI)

United StatesStarted: Jan 2017Est. completion: May 2026Updated: Mar 2026

Phase 2Active, Not Recruiting

NCT06638931

Agnostic Therapy in Rare Solid Tumors

Sponsor:Instituto do Cancer do Estado de São Paulo

BrazilStarted: Jul 2024Est. completion: May 2028Updated: May 2025

Stay informed about clinical trials for Metaplastic Breast Carcinoma.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 20, 2026 at 5:47 PM